Author: Denise Baez DG Alerts The American Society of Hematology (ASH) has published new guidelines on the use of anticoagulation for thromboprophylaxis in patients with coronavirus disease 2019 (COVID-19) who are acutely ill or hospitalised and do not have confirmed or suspected venous thromboembolism (VTE). Although the optimal strategy for thromboprophylaxis in these patients remains […]
Read MoreAuthor: Michael Walter Cardiovascular Business News A new feature in the Apple iPhone 12 appears to have an unexpected—and potentially dangerous—side effect: it can deactivate a person’s implantable cardiac device. Cardiologists at the Henry Ford Heart & Vascular Institute discovered the issue, passing an iPhone 12 Pro over the chest of a patient with a […]
Read MoreDG Journal Club AUTHORS Lisa Bagley, Anna Kordun et al. Paediatr Anaesth. 2021 Feb BACKGROUND Anaphylaxis to propofol is rare, however providers face a clinical quandary as medication warnings still exist regarding propofol administration to egg-, soy-, and peanut-allergic patients. AIMS The primary aim evaluated the rate of allergic reactions during propofol-containing anesthesia in patients […]
Read MoreAuthors: Ian J. Welsby, B.Sc., M.B.B.S. et al Anesthesiology March 2021, Vol. 134, 395–404. Background Removal of cytokines, chemokines, and microvesicles from the supernatant of allogeneic erythrocytes may help mitigate adverse transfusion reactions. Blood bank–based washing procedures present logistical difficulties; therefore, we tested the hypothesis that on-demand bedside washing of allogeneic erythrocyte units is capable of […]
Read MoreAPSF Newsletter, February 2021 Dear RAPID Response: The global crisis due to COVID-19 has permeated every aspect of our health care systems. Concerns about the biohazard of SARS-CoV-2, spread and contact transmission to patients, health care personnel, environment, and equipment have been widespread, especially with regards to procedures that generate aerosols (AGPs).1-3 Transmission of the virus […]
Read More